Similarly, high expression of SMARCA1 was associated with poor disease-free survival (DFS) for LUAD (P = 0.037),lung squamous cell carcinoma (LUSC) (P = 0.013), mesothelioma (MESO) (P = 0.041), adrenocortical carcinoma (ACC) (P = 0.0073), COAD (P = 0.034) and LGG (P = 0.035), low expression in THCA (P = 0.0074) and KIRC (P = 0.021) (Fig 5B). This evidence concerns the gene SMARCA1 and adrenal cortex carcinoma.